Manuscripts
Showing 1530 manuscripts.
Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living With HIV in the United States
Citation
Larry K Brown, Miriam Chernoff, Betsy D Kennard, Graham J Emslie, Kathryn Lypen, Sarah Buisson, Adriana Weinberg, Laura B Whiteley, Shirley Traite, Chelsea Krotje, Lauren Harriff, Ellen Townley, Amber Bunch, Murli Purswani, Ray Shaw, Stephen A Spector, Allison Agwu, David E Shapiro, IMPAACT 2002 team. Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living With HIV in the United States. Journal of Acquired Immune Deficiency Syndromes. 2021. 88(5): 497-505. PMID: 34483297
Year
Journal
Study
Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s
Citation
Kristina M. Brooks, Mauricio Pinilla, Alice M. Stek, David E. Shapiro, Emily Barr, Irma L. Febo, Mary E. Paul, Jaime G. Deville, Kathleen George, Kevin Knowles, Kittipong Rungruengthanakit, Renee Browning, Nahida Chakhtoura, Edmund V. Capparelli, Mark Mirochnick, Brookie M. Best, IMPAACT P1026s Protocol Team. Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s. Journal of Acquired Immune Deficiency Syndromes. 2022. 90: 343-350. PMID: 35195573
Year
Journal
Study
Emergence of Resistance in HIV-1 Integrase With Dolutegravir Treatment in a Pediatric Population From the IMPAACT P1093 Study
Citation
Cindy Vavro, Theodore Ruel, Andrew Wiznia, Nicole MontaƱez, Keith Nangle, Joseph Horton, Ann Buchanan, Eugene Stewart, Paul Palumbo. Emergence of Resistance in HIV-1 Integrase With Dolutegravir Treatment in a Pediatric Population From the IMPAACT P1093 Study. Antimicrobial Agents and Chemotherapy. 2022. 66: e0164521. PMID: 34694878
Year
Journal
Study
Optimizing Dolutegravir Initiation in Neonates using Population Pharmacokinetic Modeling and Simulation
Citation
Joseph Piscitelli, Mina Nikanjam, Brookie M. Best, Edward Acosta, Mark Mirochnick, Diana F. Clarke, Edmund V. Capparelli, Jeremiah D. Momper. Optimizing Dolutegravir Initiation in Neonates using Population Pharmacokinetic Modeling and Simulation. Journal of Acquired Immune Deficiency Syndromes. 2022. 89: 108-114. PMID: 34629412
Year
Journal
Study
Pharmacokinetics of Atazanavir Boosted With Cobicistat in Pregnant and Postpartum Women With HIV
Citation
Jeremiah D Momper, Jiajia Wang, Alice Stek, David E Shapiro, Kathleen M Powis, Kathleen Powis, Mary E Paul, Martina L Badell, Renee Browning, Nahida Chakhtoura, Kayla Denson, Kittipong Rungruengthanakit, Kathleen George, Edmund V Capparelli, Mark Mirochnick, Brookie M Best, IMPAACT P1026s Protocol Team. Pharmacokinetics of Atazanavir Boosted With Cobicistat in Pregnant and Postpartum Women With HIV. Journal of Acquired Immune Deficiency Syndromes. 2022. 89: 303-309. PMID: 34732682
Year
Journal
Study
Ethically designing research to inform multidimensional, rapidly evolving policy decisions: Lessons learned from the PROMISE HIV Perinatal Prevention Trial
Citation
Seema K. Shah, Alex John London, Lynne Mofenson, James V. Lavery, Grace John-Stewart, Patricia Flynn, Gerhard Theron, Shrikhant I. Bangdiwala, Dhayendre Moodley, Lameck Chinula, Lee Fairlie, Tumalano Sekoto, Tebogo J. Kakhu, Avy Violari, Sufia Dadabhai, Katie McCarthy, Mary Glenn Fowler. Ethically designing research to inform multidimensional, rapidly evolving policy decisions: Lessons learned from the PROMISE HIV Perinatal Prevention Trial. Clinical Trials. 2021. 18: 681-689. PMID: 34524048
Year
Journal
Study
Impact of CYP2B6 Genotype, TB Therapy and Formulation on Efavirenz Pharmacokinetics in Infants and Children Under 40 Months of Age
Citation
Mina Nikanjam, Lana Tran, Ellen G. Chadwick , Mutsa Bwakura-Dangarembizi, Carolyn Bolton Moore, Pearl Samson, Stephen A Spector, Nahida Chakhtoura, Patrick Jean-Philippe, Lisa Frenkel, Bonnie Zimmer, Alex Benns, Jennifer Libous, Edmund V. Capparelli. Impact of CYP2B6 Genotype, TB Therapy and Formulation on Efavirenz Pharmacokinetics in Infants and Children Under 40 Months of Age. AIDS. 2022. 36: 525-532. PMID: 34873089
Year
Journal
Study
Coordination of inflammatory responses in children with perinatally acquired HIV infection
Citation
Adriana Weinberg, Mark J. Giganti, Patricia A. Sirois, Grace Montepiedra, Jennifer Canniff, Allison Agwu, Michael J. Boivin, Suad Kapetanovic, Mark J. Abzug, International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) network. Coordination of inflammatory responses in children with perinatally acquired HIV infection. AIDS. 2022. 36: 1117-1127. PMID: 35442223
Year
Journal
Study
Forty-eight Week Outcomes of a Site-Randomized Trial of Combined Cognitive Behavioral Therapy and Medication Management Algorithm for Treatment of Depression Among Youth Living with HIV in the United States
Citation
Larry K. Brown, Kristin Baltrusaitis, Betsy D. Kennard, Graham J. Emslie, Miriam Chernoff, Sarah Buisson, Kathryn Lypen, Laura B. Whiteley, Shirley Traite, Chelsea Krotje, Kevin Knowles, Ellen Townley, Jaime Deville, Megan Wilkins, Dan Reirden, Mary Paul, Christy Beneri, David E. Shapiro, IMPAACT 2002 team. Forty-eight Week Outcomes of a Site-Randomized Trial of Combined Cognitive Behavioral Therapy and Medication Management Algorithm for Treatment of Depression Among Youth Living with HIV in the United States. Journal of Acquired Immune Deficiency Syndromes. 2022. 91: 296-304. PMID: 35839439